Objectives: To understand how a statewide data infrastructure, including clinical and multipayer claims data, can inform preventive care and reduce medical expenditures for patients with diabetes.
Study Design: A retrospective 1-year cross-sectional analysis of claims linked to clinical data for 6719 patients with diabetes in 2014 to evaluate impacts of comorbidities on the total cost of care.
Methods: Initially, variation in healthcare expenditures was examined versus a measure of disease control (most recent glycated hemoglobin [A1C] test results).
Background: As the emphasis in health reform shifts to value-based payments, especially through multi-payer initiatives supported by the U.S. Center for Medicare & Medicaid Innovation, and with the increasing availability of statewide all-payer claims databases, the need for an all-payer, "whole-population" approach to facilitate the reporting of utilization, cost, and quality measures has grown.
View Article and Find Full Text PDF